Market Definition

Although fiducial markers may look a complex term to understand, but in simple way fiducial means fixed which is then referred for any king of further expansion. In medical terms the fiducial maker is a small object that is placed in or on the body to mark a part for radiation treatment or some sort of surgery. For instance, a small gold seed may be put into the prostate to mark a tumour in the particular body part, before the actual radiation therapy. This allows the doctors to give higher doses of radiation to the tumour with less harm to the side by healthy tissue. It’s very essential to understand how these markers work, how many marks to be drawn before doing any kind of surgery or therapy. There are variety of markers available in the market like metal-based markers, polymer-based markers, gold-based markers and many such. Thus, the implementation of fiducial markets is offering a well-organized radiation therapy and witnesses to grow each day. 

Report Scope

The global fiducial markers market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share.

Major Market Players

CIVCO RADIOTHERAPY, Boston Scientific Corporation, IZI Medical Products, IBA, Naslund Medical AB, Medtronic, Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler., Innovative Oncology Solutions, QlRad Inc, Stellar Medical, JJ-MedTech, QFIX, Varian Medical Systems, Inc, Beekley Corporation, Innomedicus Ag, Meditronix Corporation and Seedos Ltd. These are the companies that are leading in the global fiducial markers market.

The Fiducial Markers market report has been categorized as below

By Cancer Type

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Gastric Cancer
  • Other Cancers

 By Product

  • Metal-based Markers
    • Pure Gold
    • Gold Alloys
    • Other Metal-based Markers
  • Other Fiducial Markers

By End User

  • Hospitals & Outpatient Facilities
  • Independent Radiotherapy Centers
  • Cancer Research Centers

By Modality

  • CT/CBCT
  • MRI
  • Ultrasound
  • Radiotherapy

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The years considered for the global fiducial markers study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year - 2022
  • Forecast period - 2021 to 2027

Key Questions Addressed by the Report

  • New products/service competitor are exploring?
  • Key players in the Fiducial Markers market and how intense is the competition?
  • What are the upcoming industry trends that manufacturers are focusing on in the future updates?
  • For each segment, what are the significant opportunities in the market?
  • What are the key growth strategies adopted by major market players in the market?
  • What are the key success strategies adopted by major competitors in the market? 

Why Buy this Report:

  • Gain comprehensive insights on the Fiducial Markers industry & market trends
  • Note complete analysis of the market status
  • Recognize the market opportunities and growth segments
  • Evaluating business segments & product portfolios, and interpret competitive dynamics
  • Facilitate strategy planning and industry dynamics to strengthen decision making

Report Table Of Content

1.   Fiducial Markers Introduction

1.1. Key Insights

1.2. Report Overview

1.3. Markets Covered

1.4. Stakeholders

2.   Research Methodology

2.1. Research Scope

2.2. Market Research Process

2.3. Research Data Analysis

2.4. Market Size Estimation

3.   Executive Summary

4.   Market Overview

4.1.   Introduction

4.2.   Market Drivers and Restraints

5.   Fiducial Markers Market, By Cancer Type

5.1.   Key Points

5.2.   Prostate Cancer

5.3.   Lung Cancer

5.4.   Breast Cancer

5.5.   Gastric Cancer

5.6.   Other Cancers

6.   Fiducial Markers Market, By Product

6.1.   Key Points

6.2.   Metal-based Markers

6.3.   Other Fiducial Markers

7.   Fiducial Markers Market, By End Users

7.1.   Key Points

7.2.   Hospitals & Outpatient Facilities

7.3.   Independent Radiotherapy Centers

7.4.   Cancer Research Centers

8.   Fiducial Markers Market, By Modality

8.1.   Key Points

8.2.   CT/CBCT

8.3.   MRI

8.4.   Ultrasound

8.5.   Radiotherapy

9.   Fiducial Markers Market, By Region

9.1.     Key Points

9.2.     North America

9.2.1.     US

9.2.2.     Canada

9.2.3.     Mexico

9.3.     Europe

9.3.1.     Germany

9.3.2.     France

9.3.3.     Italy

9.3.4.     UK

9.3.5.     Rest of World

9.4.     Asia Pacific

9.4.1.     Japan

9.4.2.     China

9.4.3.     India

9.4.4.     Australia

9.4.5.     Rest of Asia Pacific

9.5.     Rest of the World

9.5.1.     South America

9.5.2.     Middle East and Africa

10. Company Profile

(Profile contain company overview, products/services, financials & recent developments)

10.1. Exxon Mobil Corporation

10.1.1.  Company Overview

10.1.2.  Financial Highlights

10.1.3.  Product/Services

10.1.4.  Recent Developments

10.2. CIVCO RADIOTHERAPY

10.2.1.  Company Overview

10.2.2.  Financial Highlights

10.2.3.  Product/Services

10.2.4.  Recent Developments

10.3. Boston Scientific Corporation

10.3.1.  Company Overview

10.3.2.  Financial Highlights

10.3.3.  Product/Services

10.3.4.  Recent Developments

10.4. ZI Medical Products

10.4.1.  Company Overview

10.4.2.  Financial Highlights

10.4.3.  Product/Services

10.4.4.  Recent Developments

10.5. IBA

10.5.1.  Company Overview

10.5.2.  Financial Highlights

10.5.3.  Product/Services

10.5.4.  Recent Developments

10.6. Naslund Medical AB

10.6.1.  Company Overview

10.6.2.  Financial Highlights

10.6.3.  Product/Services

10.6.4.  Recent Developments

10.7. Medtronic

10.7.1.  Company Overview

10.7.2.  Financial Highlights

10.7.3.  Product/Services

10.7.4.  Recent Developments

10.8. Best Medical International, Inc

10.8.1.  Company Overview

10.8.2.  Financial Highlights

10.8.3.  Product/Services

10.8.4  Recent Developments

10.9. Nanovi A/S

10.9.1.  Company Overview

10.9.2.  Financial Highlights

10.9.3.  Product/Services

10.9.4.  Recent Developments

10.10. Carbon Medical Technologies

10.10.1.  Company Overview

10.10.2.  Financial Highlights

10.10.3.  Product/Services

10.10.4.  Recent Developments

10.11. Eckert & Ziegler

10.111.  Company Overview

10.11.2.  Financial Highlights

10.11.3.  Product/Services

10.11.4.  Recent Developments

10.12. Innovative Oncology Solutions

10.12.1.  Company Overview

10.12.2.  Financial Highlights

10.12.3.  Product/Services

10.12.4. Recent Developments

10.13. QlRad Inc

10.13.1.  Company Overview

10.13.2.  Financial Highlights

10.13.3.  Product/Services

10.13.4.  Recent Developments

10.14. Stellar Medical

10.14.1.  Company Overview

10.14.2.  Financial Highlights

10.14.3.  Product/Services

10.14.4.  Recent Developments

10.15. JJ-Medtech, QFIX

10.15.1.  Company Overview

10.15.2.  Financial Highlights

10.15.3.  Product/Services

10.15.4.  Recent Developments

10.16. Varian Medical Systems, Inc

10.16.1.  Company Overview

10.16.2.  Financial Highlights

10.16.3.  Product/Services

10.16.4.  Recent Developments

10.17. Beekley Corporation

10.17.1.  Company Overview

10.17.2.  Financial Highlights

10.17.3.  Product/Services

10.17.4.  Recent Developments

10.18. Innomedicus Ag, Meditronix Corporation

10.18.1.  Company Overview

10.18.2.  Financial Highlights

10.18.3.  Product/Services

10.18.4.  Recent Developments

10.19. Seedos Ltd

10.19.1.  Company Overview

10.19.2.  Financial Highlights

10.19.3.  Product/Services

10.19.4.  Recent Developments

The Fiducial Markers market report has been categorized as below

By Cancer Type

  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Gastric Cancer
  • Other Cancers

 By Product

  • Metal-based Markers
    • Pure Gold
    • Gold Alloys
    • Other Metal-based Markers
  • Other Fiducial Markers

By End User

  • Hospitals & Outpatient Facilities
  • Independent Radiotherapy Centers
  • Cancer Research Centers

By Modality

  • CT/CBCT
  • MRI
  • Ultrasound
  • Radiotherapy

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Licence Option

  • Single User 1500 USD
  • Multiple User 3500 USD

Quality assurance

A testimonial for service in the form of BBB “A” Accreditation.

Your personal and confidential information is safe and secure.

  - Information security

© 2021 Whipsmart. All Rights Reserved.

Terms of use| Site Map